Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 162.58 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 183.15 millions during the year-ago period.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 15.67  millions as against Rs. 16.16 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 23.43 millions from 23.26 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 162.58 183.15 -11.23 162.58 183.15 -11.23 858.31 744.57 15.28
Other Income 3.76 3.72 1.08 3.76 3.72 1.08 15.81 8.41 87.99
PBIDT 23.43 23.26 0.73 23.43 23.26 0.73 140.09 117.94 18.78
Interest 0.23 0.36 -36.11 0.23 0.36 -36.11 1.81 1.58 14.56
PBDT 23.20 22.90 1.31 23.20 22.90 1.31 138.28 116.36 18.84
Depreciation 2.25 1.31 71.76 2.25 1.31 71.76 5.75 5.68 1.23
PBT 20.95 21.59 -2.96 20.95 21.59 -2.96 132.53 110.68 19.74
TAX 5.28 5.43 -2.76 5.28 5.43 -2.76 33.84 28.63 18.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 4.39 -0.07 -6371.43
PAT 15.67 16.16 -3.03 15.67 16.16 -3.03 98.69 82.05 20.28
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 14.41 12.70 13.48 14.41 12.70 13.48 16.32 15.84 3.04
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..